“`html

Eric J. Lenze, MD, the Wallace and Lucille K. Renard Professor and leader of the Department of Psychiatry at Washington University School of Medicine in St. Louis, along with his group, is among the Top 40 Milestone 1 award recipients in XPRIZE Healthspan. This seven-year, worldwide challenge motivates teams to devise and trial therapeutics aimed at enhancing healthy aging and bridging the divide between human lifespan and healthspan — the years a person generally maintains good health and enjoys a high standard of living concerning their physical and mental wellness.

Out of over 600 registered teams from 58 nations, 40 teams were acknowledged as the leading semifinalists. These teams proposed a therapeutic strategy that could potentially delay age-associated physical, cognitive, or immune-system deterioration by at least 10 years, “with an ambitious aim of 20 years,” as per XPRIZE’s account of the contest.

The leading 40 semifinalists, including Lenze’s group, will each receive $250,000 to assist them in the subsequent phase of the competition — initial clinical trials. Lenze’s experiment will evaluate a personalized intervention comprising three elements: strengthening healthy habits such as nutrition, physical activity, and adequate sleep; refining medical treatments with customized management of health issues; and boosting cognitive capability with pharmacological and training methods. This preliminary trial will concentrate on short-term results in preparation for an extended trial.

Following the outcomes of the semifinal trials, XPRIZE will identify 10 finalists in 2026 to receive a subsequent $10 million award. If chosen, Lenze’s team will evaluate their therapeutic method in a larger clinical trial, aspiring to secure the competition’s grand prize — up to $81 million — should they succeed in reaching the objective of reversing aging-related declines by 20 years.

The post Lenze named XPRIZE Healthspan semifinalist  appeared first on The Source.

“`